Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-28
2011-06-28
Young, Shawquia (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S329000, C514S422000, C514S602000, C546S223000, C548S557000, C548S953000, C564S092000
Reexamination Certificate
active
07968534
ABSTRACT:
The present invention is directed to a compound of formula (I):wherein Ar1, Ar2, Ar3, R1 and T are as defined herein, its preparation, pharmaceutical composition and uses as orexin 2 receptor antagonist.
REFERENCES:
patent: WO 01/81308 (2001-11-01), None
patent: WO 2004/033418 (2004-04-01), None
patent: WO 2004/041807 (2004-05-01), None
patent: WO 2006/024779 (2006-03-01), None
Vippagunta, et al. Advanced Drug Delivery Reviews 48 (2001) 3-26.
Document No. 149:53987, retrieved from CAPLUS on Aug. 23, 2010.
4-Chloro-N-(1-Methylpiperidin-4-yl)-N-[1-(2-Phenylethyl)Piperidin-4-yl]Benzenesulfonamide, Peakdale Screening Library, Database Chemcats [Online] abstract, (2006).
Courtemanche Gilles
Despeyroux Pierre
Fontaine Evelyne
Gal Claudine Serradeil-Le
Rochard Pierrick
Lin Jiang
Sanofi-Aventis
Young Shawquia
LandOfFree
Sulfonamide derivatives, preparation thereof and use thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide derivatives, preparation thereof and use thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide derivatives, preparation thereof and use thereof... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2689992